These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11185897)

  • 1. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    Biol Blood Marrow Transplant; 2000; 6(6a):7-83. PubMed ID: 11185897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    MMWR Recomm Rep; 2000 Oct; 49(RR-10):1-125, CE1-7. PubMed ID: 11718124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing opportunistic infections in bone marrow transplant recipients.
    Dykewicz CA
    Transpl Infect Dis; 1999 Mar; 1(1):40-9. PubMed ID: 11428970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
    Dykewicz CA; ; ;
    Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections.
    Dykewicz CA; ; ;
    Biol Blood Marrow Transplant; 2001; 7 Suppl():19S-22S. PubMed ID: 11777100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
    Sullivan KM; Dykewicz CA; Longworth DL; Boeckh M; Baden LR; Rubin RH; Sepkowitz KA; ; ;
    Hematology Am Soc Hematol Educ Program; 2001; ():392-421. PubMed ID: 11722995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.
    Zuccotti G; Strasfeld L; Weinstock DM
    Expert Opin Pharmacother; 2005 Aug; 6(10):1669-79. PubMed ID: 16086653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation.
    CDC, Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation
    Cytotherapy; 2001; 3(1):41-54. PubMed ID: 12028843
    [No Abstract]   [Full Text] [Related]  

  • 9. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
    Unal E; Yen C; Saiman L; George D; Della-Latta P; van de Ven C; Morris E; Bradley MB; Del Toro G; Garvin J; Bhatia M; Schwartz J; Satwani P; Roman E; Cooney E; Wolownik K; Hawks R; Foley S; Cairo MS
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1188-97. PubMed ID: 17085312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital infection control in hematopoietic stem cell transplant recipients.
    Dykewicz CA
    Emerg Infect Dis; 2001; 7(2):263-7. PubMed ID: 11294720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
    Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C;
    Bone Marrow Transplant; 2005 Apr; 35(8):737-46. PubMed ID: 15750612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinations against infectious diseases in hematopoietic stem cell transplant recipients.
    Goldberg SL; Cicogna CE; Rowley SD; Pecora AL
    Oncology (Williston Park); 2003 Apr; 17(4):539-54, 559; discussion 559-60, 564-5. PubMed ID: 12735146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusarium infection in hematopoietic stem cell transplant recipients.
    Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
    Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues.
    Weinstock DM; Boeckh M; Boulad F; Eagan JA; Fraser VJ; Henderson DK; Perl TM; Yokoe D; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):603-8. PubMed ID: 15301035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
    Science M; Robinson PD; MacDonald T; Rassekh SR; Dupuis LL; Sung L
    Pediatr Blood Cancer; 2014 Mar; 61(3):393-400. PubMed ID: 24424789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.